James Hall
Amministratore Delegato presso Betagenon Sweden AB
Posizioni attive di James Hall
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Amministratore Delegato | 27/05/2021 | - |
Storia della carriera di James Hall
Formazione di James Hall
| University of Oxford | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svezia | 2 |
| Regno Unito | 2 |
Posizioni
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Health Technology |
- Borsa valori
- Insiders
- James Hall
- Esperienza
